RESTEGHINI, CARLO
RESTEGHINI, CARLO
Universita' degli Studi di MILANO
HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patients
2023 S. Cavalieri, I. Nuzzolese, A. Ottini, C. Bergamini, C. Resteghini, E. Colombo, S. Alfieri, P. Quattrone, G. Calareso, N.A. Iacovelli, M. Franceschini, L. Licitra
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience
2023 S. Cavalieri, F. Platini, F. Barretta, I. Nuzzolese, A. Ottini, C. Bergamini, C. Resteghini, E. Colombo, N.A. Iacovelli, M. Franceschini, G. Calareso, P. Di Pede, G. De Feo, M. Gandelli, L. Toffolatti, M. Guglielmo, C.I. Ripamonti, L. Cosmai, L. Licitra, S. Alfieri
The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients
2022 S. Cavalieri, P. Bossi, G. Infante, R. Miceli, N.A. Iacovelli, E. Ivaldi, L.D. Locati, C. Bergamini, C. Resteghini, I. Nuzzolese, S. Alfieri, E. Colombo, R. Ingargiola, M. Franceschini, G. Calareso, L. Licitra, E. Orlandi
Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
2021 S. Cavalieri, D.M. Filippini, A. Ottini, C. Bergamini, C. Resteghini, E. Colombo, R. Lombardo, I. Nuzzolese, S. Alfieri, L. Licitra, L.D. Locati
Monitoring patients with head and neck cancer for flu-like symptoms during the COVID-19 pandemic
2021 S. Cavalieri, E. Colombo, A. Bottiglieri, G. Massa, F. Platini, A. Ottini, D. Filippini, E. Zattarin, C. Bergamini, C. Resteghini, S. Alfieri, V. Di Martino, V. Tiraferri, L. Locati, L. Licitra
Relevance of apparent diffusion coefficient features for a radiomics-based prediction of response to induction chemotherapy in sinonasal cancer
2020 M. Bologna, G. Calareso, C. Resteghini, S. Sdao, E. Montin, V. Corino, L. Mainardi, L. Licitra, P. Bossi
Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands
2020 S. Cavalieri, L. Mariani, V. Vander Poorten, L. Van Breda, M.C. Cau, S. Lo Vullo, S. Alfieri, C. Resteghini, C. Bergamini, E. Orlandi, G. Calareso, P. Clement, E. Hauben, F. Platini, P. Bossi, L. Licitra, L.D. Locati
Prognostic role of primary tumor, nodal neck, and retropharyngeal GTVs for unresectable sinonasal cancers treated with IMRT and chemotherapy
2019 L. Ferella, A. Cavallo, R. Miceli, N.A. Iacovelli, T. Giandini, E. Pignoli, G. Calareso, P. Bossi, C. Resteghini, G.L. Gravina, P. Nicolai, P. Castelnuovo, C. Piazza, L. Licitra, C. Fallai, E. Orlandi
Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow-up
2019 M. Imbimbo, S. Alfieri, L. Botta, C. Bergamini, A. Gloghini, G. Calareso, E. Orlandi, N.A. Iacovelli, M. LO GUZZO, R. Granata, C. Resteghini, L. Locati, C.C. Volpi, L. Licitra, P. Bossi
A pilot study of a smartphone-based monitoring intervention on head and neck cancer patients undergoing concurrent chemo-radiotherapy
2019 E.M. Zini, G. Lanzola, S. Quaglini, P. Bossi, L. Licitra, C. Resteghini
Phase II trial with axitinib in recurrent and/or metastatic salivary gland cancers of the upper aerodigestive tract
2019 L.D. Locati, S. Cavalieri, C. Bergamini, C. Resteghini, S. Alfieri, G. Calareso, P. Bossi, F. Perrone, E. Tamborini, P. Quattrone, R. Granata, D. Galbiati, F. Platini, E. Orlandi, L. Mariani, L. Licitra
PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with Anti-Epidermal Growth Factor Receptor Agents
2019 S. Cavalieri, F. Perrone, M. Milione, A. Bianco, S. Alfieri, L.D. Locati, C. Bergamini, C. Resteghini, D. Galbiati, F. Platini, L. Licitra, P. Bossi
Locally advanced epithelial sinonasal tumors: The impact of multimodal approach
2019 E. Orlandi, S. Cavalieri, R. Granata, P. Nicolai, P. Castelnuovo, C. Piazza, A. Schreiber, M. Turri-Zanoni, P. Quattrone, R. Miceli, G. Infante, F. Sessa, C. Facco, G. Calareso, N.A. Iacovelli, D. Mattavelli, A. Paderno, C. Resteghini, L.D. Locati, L. Licitra, P. Bossi
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer
2018 S. Cavalieri, F. Perrone, R. Miceli, P.A. Ascierto, L.D. Locati, C. Bergamini, R. Granata, S. Alfieri, C. Resteghini, D. Galbiati, A. Busico, N. Paielli, R. Patuzzo, A. Maurichi, G. Gallino, R. Ruggeri, L. Mariani, M. Palla, L. Licitra, P. Bossi
Big Data in Head and Neck Cancer
2018 C. Resteghini, A. Trama, E. Borgonovi, H. Hosni, G. Corrao, E. Orlandi, G. Calareso, L. De Cecco, C. Piazza, L. Licitra, L. Mainardi
Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients
2017 C. Resteghini, S. Cavalieri, D. Galbiati, R. Granata, S. Alfieri, C. Bergamini, P. Bossi, L.F.L. Licitra, L..D. Locati
RANK expression in EBV positive nasopharyngeal carcinoma metastasis: A ready-to-treat target?
2017 C. Resteghini, S. Alfieri, P. Quattrone, F. Dominoni, G. Garzone, E. Orlandi, L. Locati, C. Bergamini, D. Galbiati, N.A. Iacovelli, C. Fallai, L. Licitra, P. Bossi
Systemic therapy in metastatic salivary gland carcinomas : a pathology-driven paradigm?
2017 S. Alfieri, R. Granata, C. Bergamini, C. Resteghini, P. Bossi, L.F. Licitra, L.D. Locati
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy
2016 P. Bossi, C. Bergamini, R. Miceli, A. Cova, E. Orlandi, C. Resteghini, L. Locati, S. Alfieri, M. Imbimbo, R. Granata, L. Mariani, N.A. Iacovelli, V. Huber, A. Cavallo, L. Licitra, L. Rivoltini
Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma
2016 P. Bossi, C. Resteghini, N. Paielli, L. Licitra, S. Pilotti, F. Perrone